331
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Research and development of anti-Alzheimer’s drugs: an analysis based on technology flows measured by patent citations

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Rongrong Li, Xuefeng Wang, Yuqin Liu, Shuo Zhang & Omer Hanif. (2021) Research status and collaboration analysis based on big data mining: an empirical study of Alzheimer's disease. Technology Analysis & Strategic Management 33:4, pages 379-395.
Read now
Jingwen Qu, Jiahong Lu & Yuanjia Hu. (2019) Research and development of anti-Parkinson’s drugs: an analysis from the perspective of technology flows measured by patent citations. Expert Opinion on Therapeutic Patents 29:2, pages 127-135.
Read now
Kunmeng Liu, Hui-Heng Lin, Rongbiao Pi, Shinghung Mak, Yifan Han & Yuanjia Hu. (2018) Research and development of anti-Alzheimer’s disease drugs: an update from the perspective of technology flows. Expert Opinion on Therapeutic Patents 28:4, pages 341-350.
Read now
Xiangjun Kong, Qianru Zhang, Yunfeng Lai, Hao Hu, Xin Chen & Yuanjia Hu. (2018) Global patent landscape of programmed cell death 1: implications of the rapid expansion. Expert Opinion on Therapeutic Patents 28:1, pages 69-80.
Read now
Meng Zhang, Xiangjun Kong, Jun Zheng, Jian-bo Wan, Yitao Wang, Yuanjia Hu & Rong Shao. (2016) Research and development of antibiotics: insights from patents and citation network. Expert Opinion on Therapeutic Patents 26:5, pages 617-627.
Read now
Xiaomei Geng, Xiangjun Kong, Hao Hu, Jiayu Chen, Fengqing Yang, Hongyu Liang, Xin Chen & Yuanjia Hu. (2015) Research and development of therapeutic mAbs: An analysis based on pipeline projects. Human Vaccines & Immunotherapeutics 11:12, pages 2769-2776.
Read now
Xiangjun Kong, Yuanjia Hu, Zhifang Cai, Fengqing Yang & Qianru Zhang. (2015) Dendritic-cell-based technology landscape: Insights from patents and citation networks. Human Vaccines & Immunotherapeutics 11:3, pages 682-688.
Read now

Articles from other publishers (8)

Jiashun HuangWeiping LiXijie HuangYuandi WangLijia Guo. (2020) Technology and Innovation in China: A Patent Citation-based Analysis. Science, Technology and Society 26:2, pages 344-365.
Crossref
Sun Minghan, Zhu Xiuzhu & Jiang Man. (2020) Exploring the innovation landscape of bamboo fiber technologies from global patent data perspective. Cellulose 27:16, pages 9137-9156.
Crossref
Gizem Tezel, Selin Seda Timur, İsmail Bozkurt, Ö. Faruk Türkoğlu, İpek Eroğlu, Emirhan Nemutlu, Levent Öner & Hakan Eroğlu. (2019) A Snapshot on the Current Status of Alzheimer’s Disease, Treatment Perspectives, <i>in-Vitro</i> and <i>in-Vivo</i> Research Studies and Future Opportunities. Chemical and Pharmaceutical Bulletin 67:10, pages 1030-1041.
Crossref
Ming Ming Wen, Noha S. El-Salamouni, Wessam M. El-Refaie, Heba A. Hazzah, Mai M. Ali, Giovanni Tosi, Ragwa M. Farid, Maria J. Blanco-Prieto, Nashiru Billa & Amira S. Hanafy. (2017) Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release 245, pages 95-107.
Crossref
Chuoji Huang, Hui Heng Lin, Jian-bo Wan, Chengwei He & Yuanjia Hu. (2016) Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations. PLOS ONE 11:10, pages e0164328.
Crossref
Jingyun Ni, Jianbo Wan, Xiangjun Kong, Yong Cai, Fengqing Yang, Yitao Wang & Yuanjia Hu. (2015) Pharmaceutical Technology Licensing: An Analysis in the Field of Cardiovascular Disease. Journal of Pharmaceutical Innovation 11:1, pages 34-45.
Crossref
Jingyun Ni, Rong Shao, Carolina Oi Lam Ung, Yitao Wang, Yuanjia Hu & Yong Cai. (2015) Valuation of Pharmaceutical Patents: A Comprehensive Analytical Framework Based on Technological, Commercial, and Legal Factors. Journal of Pharmaceutical Innovation 10:3, pages 281-285.
Crossref
Taizong Wu, Cheng Jiang, Ling Wang, Susan L. Morris-Natschke, Hui Miao, Lianquan Gu, Jun Xu, Kuo-Hsiung Lee & Qiong Gu. (2015) 3,5-Diarylpyrazole Derivatives Obtained by Ammonolysis of the Total Flavonoids from Chrysanthemum indicum Extract Show Potential for the Treatment of Alzheimer’s Disease . Journal of Natural Products 78:7, pages 1593-1599.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.